NEUWAY Trademark

Trademark Overview


On Monday, January 28, 2019, a trademark application was filed for NEUWAY with the United States Patent and Trademark Office. The USPTO has given the NEUWAY trademark a serial number of 88278750. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by NEUWAY Pharma GmbH. The NEUWAY trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties

Chemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof; diagnostic preparations for medical and veterinary use; medicinal preparations, pharmaceutical preparations and pharmaceutical substances for the prevention and ...

Chemical, biological, biochemical and biotechnological products and preparations, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof for laboratory or research use and manufacturing use

Scientific research and development for others, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development as well as biotechnological services with regard to manufacturing pharmaceutical preparations, active substance carriers, active substance transport systems, drug delivery systems and active substance implants for use on humans or animals, for others; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene the...
neuway

General Information


Serial Number88278750
Word MarkNEUWAY
Filing DateMonday, January 28, 2019
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6466029
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements


Goods and ServicesManufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties
Goods and ServicesChemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof; diagnostic preparations for medical and veterinary use; medicinal preparations, pharmaceutical preparations and pharmaceutical substances for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; vaccines; adjuvants, carriers for active ingredients, drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents for medical use in humans or animals; biological implants comprising active ingredients; drug delivery systems consisting of proteins in the form of capsids or particles; drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents
Goods and ServicesChemical, biological, biochemical and biotechnological products and preparations, namely small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof for laboratory or research use and manufacturing use
Goods and ServicesScientific research and development for others, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development as well as biotechnological services with regard to manufacturing pharmaceutical preparations, active substance carriers, active substance transport systems, drug delivery systems and active substance implants for use on humans or animals, for others; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 20, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNEUWAY Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBonn 53117
DE

Party NameNEUWAY Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBonn 53175
DE

Party NameNEUWAY Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBonn 53175
DE

Trademark Events


Event DateEvent Description
Tuesday, April 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 27, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, July 1, 2021NOTICE OF ALLOWANCE CANCELLED
Thursday, July 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 1, 2021TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 18, 2021CASE RETURNED TO EXAMINATION
Thursday, March 18, 2021NOTICE OF ALLOWANCE CANCELLED
Friday, October 30, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, October 29, 2020ASSIGNED TO PETITION STAFF
Saturday, September 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 24, 2020SOU EXTENSION 2 GRANTED
Thursday, September 24, 2020SOU EXTENSION 2 FILED
Thursday, September 24, 2020TEAS EXTENSION RECEIVED
Friday, September 11, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, March 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2020SOU EXTENSION 1 GRANTED
Monday, March 23, 2020SOU EXTENSION 1 FILED
Monday, March 23, 2020TEAS EXTENSION RECEIVED
Friday, March 20, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 20, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, March 20, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, March 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 20, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION E-MAILED
Friday, April 12, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 9, 2019ASSIGNED TO EXAMINER
Monday, February 25, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, February 21, 2019ASSIGNED TO LIE
Wednesday, February 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 14, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 31, 2019NEW APPLICATION ENTERED IN TRAM